Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 25, 2018

DrugPatentWatch Database Preview

Sagent Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?

SAGENT PHARMS has sixty approved drugs.

There is one tentative approval on SAGENT PHARMS drugs.

Summary for Sagent Pharms

US Patents:	0
Tradenames:	48
Ingredients:	46
NDAs:	60

Drugs and US Patents for Sagent Pharms

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sagent Pharms	METHYLPREDNISOLONE SODIUM SUCCINATE	methylprednisolone sodium succinate	INJECTABLE;INJECTION	040888-002	Jul 18, 2011	AP	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Sagent Pharms	GLYDO	lidocaine hydrochloride	JELLY;TOPICAL	201094-001	Apr 28, 2014	AT	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Sagent Pharms	GEMCITABINE HYDROCHLORIDE	gemcitabine hydrochloride	INJECTABLE;INJECTION	091597-002	May 7, 2013		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Sagent Pharms	FLUMAZENIL	flumazenil	INJECTABLE;INJECTION	090584-002	Aug 28, 2012	AP	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald

Dow

UBS

Johnson and Johnson

QuintilesIMS

McKesson

Citi

Federal Trade Commission

Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.